Employer-mandated enrollment in a high-deductible health plan did not reduce use of oral targeted anticancer medications among patients commercially insured between 2007 and 2021.
Mahnum Shahzad, PhD
Advertisement
Articles by Mahnum Shahzad, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Pharmacists Bridge the Vaccine Trust Gap as COVID-19 Persists
2
Who Recommends COVID-19 Vaccines Without ACIP?
3
Pipeline Advances in Sjögren Disease Bring Targeted Therapies Closer
4
FDA Approves Pirtobrutinib for Untreated CLL/SLL Without 17p Deletion
5